XML 74 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Sep. 30, 2019
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Operating Activities:            
Net income $ 620,327 $ 1,045,940        
Adjustments to reconcile net income to net cash used in operating activities            
Depreciation and amortization 208,537 201,267        
Warranty provision (19,516) 20,618        
Inventory obsolescence 94,415 54,854        
Share-based compensation 158,327 133,845        
Deferred income taxes 172,390 283,003        
Amortization of operating lease right of use asset 145,382        
Changes in operating assets and liabilities:            
Accounts receivable, net (2,286,618) (5,916,242)        
Inventories, net (320,998) (2,029,403)        
Prepaid expenses and other 760,823 2,136,282        
Accounts payable 604,134 (66,849)        
Accrued and other liabilities (1,918,180) (957,199)        
Net cash used in operating activities (1,780,977) (5,093,884)        
Investing Activities:            
Purchases of marketable securities (639,794) (874,353)        
Proceeds from maturities of marketable securities 588,749 982,834        
Capital expenditures (86,159) (38,813)        
Net cash (used in) provided by investing activities (137,204) 69,668        
Financing Activities:            
Proceeds from exercise of stock options 144,214 2,528        
Repurchase of common stock (1,621,022)        
Net cash provided by (used in) financing activities 144,214 (1,618,494)        
Effect of foreign exchange rate on cash 14,336 (9,734)        
Net decrease in cash, cash equivalents, and restricted cash (1,759,631) (6,652,444)        
Cash, cash equivalents and restricted cash, beginning of period 19,516,918 11,806,074 $ 11,806,074      
Cash, cash equivalents and restricted cash, end of period 17,757,287 5,153,630 19,516,918      
Cash and cash equivalents       $ 17,092,203 $ 18,819,078 $ 4,416,106
Restricted cash, current portion       269,830   397,933
Long-term restricted cash       395,254   339,591
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows 17,757,287 5,153,630 $ 11,806,074 $ 17,757,287 $ 19,516,918 $ 5,153,630
Noncash investing and financing activities:            
Change in unrealized loss on marketable securities (3,486) (613)        
Initial measurement of operating lease right of use assets and liabilities $ 7,814,701